Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462299) titled 'NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy' on March 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Condition:
Childhood Acute Lymphoblastic Leukemia
Intervention:
Drug: NUDT15/TPMT genotype-guided 6-MP dosing
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 20, 2026
Target Sample Size: 110
Countries of Recruitment:
China
To know more, vis...